Hepatic toxicity and prognosis in hepatitis C virus-infected patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy regimens: a Japanese multicenter analysis.

D, Ennishi; Y, Maeda; N, Niitsu; M, Kojima; K, Izutsu; J, Takizawa; S, Kusumoto; M, Okamoto; M, Yokoyama; Y, Takamatsu; K, Sunami; A, Miyata; K, Murayama; A, Sakai; M, Matsumoto; K, Shinagawa; A, Takaki; K, Matsuo; T, Kinoshita; M, Tanimoto

doi:10.1182/blood-2010-06-289231

Public

Hepatic toxicity and prognosis in hepatitis C virus-infected patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy regimens: a Japanese multicenter analysis.

Shared by NobleBlocks on Sep 7, 2010 • 12:00 AM UTC

Authors:

Ennishi D

Maeda Y

Niitsu N

Abstract

The influence of hepatitis C virus (HCV) infection on prognosis and hepatic toxicity in patients with diffuse large B-cell lymphoma in the rituximab era is unclear. Thus, we analyzed 553 patients, 131 of whom were HCV-positive and 422 of whom were HCV-negative, with DLBCL treated with rituximab, cyc...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!